Novalpina dispute: A masterclass in misalignment
The mid-market firm's troubles highlight the rare risk of members of a GP not seeing eye-to-eye on what's best for their LPs.
The mid-market firm's troubles highlight the rare risk of members of a GP not seeing eye-to-eye on what's best for their LPs.
Copyright PEI Media
Not for publication, email or dissemination